All those bitter are always the one who missed the boat. And some of them are trying to intrigate fear then want to collect at lower price. Just hold and see how tomorrow goes. This stock is for future.
True. I dont see any harm to hold Vaccine stock now. We will need vaccine (could be every year) to win this Covid battle. This stock is just suit to what we need now.
You know why? Because our beloved Trump will do his best to fast tracking the vaccine before Nov 2020. Why Nov? Those sharp enough may get what I mean? This is hidden gem with fast rising stock ever. You may choose to regret or buy at higher price after tomorrow
This guy is not bluffing. https://www.theedgemarkets.com/article/company-signed-mou-tripled-its-share-price "The Oxford trials also made news earlier this week when the Financial Times reported the Trump administration was considering fast-tracking the vaccine for use in the US ahead of the presidential election on Nov 3".
OISEH. Smart boys. Phase 1 phase 2 are not important. You can't imagine how important for him to win this election? How trump could win without any vaccine while US is in a mess now. Only Vaccine can help him now. What to do? Must get the vaccine before Nov! And declare his success before Russia /China. Next? Claim the victory and get credit from voter!
for me its still good...even if some bad news come... there are many vaccine candidate.. later on the ppl will pick cheaper and effective vaccine .. if im correct some news told china vaccine price is higher than expected..
goreng say goreng..dun lie to yourself say the company is good to 'invest'..need to let go if hit cl. That's it. Hold every one have a nice investing journey.
To answer your question. Which vaccine should/will Malaysia use? Guess what. It must be the the fastest, most affordable, and available vaccine from the world. Who cares it is from China, Russia, US, or Malaysia due to JV? As long as it is safe to use and Malaysia is able to purchase it with reasonable price!
Titijaya has formal agreement with Sinopharm, once the vaccines are final approved. Titijaya as the partner of Sinopharm in Malaysia, according to the agreement, Titijaya has the right to distribute the medical product to Indonesia, Thailand, Singapore, Australia and Malaysia.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Flyingwithwings
521 posts
Posted by Flyingwithwings > 2020-08-25 21:13 | Report Abuse
All those bitter are always the one who missed the boat. And some of them are trying to intrigate fear then want to collect at lower price. Just hold and see how tomorrow goes. This stock is for future.